Basic studies have shown that CysC might participate in diabetic microangiopathy by activating the neutrophil-mediated inflammatory response to cause endothelial dysfunction, or by interacting with homocysteine and cathepsin to promote the proliferation of vascular smooth muscle cells and damage to vascular endothelial cells [12,30]. Here, CTSS is linked to endothelial dysfunction.